Reintroduction Failure After Negative Food Challenges

| February 24, 2021

Reintroduction Failure After Negative Food Challenges

For today’s episode we will be reviewing three articles from the July-August 2020 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology. You can also earn CME credit by listening to this podcast! For information about CME credit or to read archived issues of Allergy Watch, head over to

Please watch out for continued discussion on this topic in the ACAAI Community on DocMatter, we’ll have key takeaways with the opportunity for ongoing conversation about today’s topic!

Article links:

Reintroduction failure after negative food challenges in adults is common and mainly due to atypical symptoms.

Acute emotional stress proposed as a risk factor for anaphylaxis in patients receiving allergen immunotherapy.

Home self-monitoring in patients with asthma using a mobile spirometry system.

Please rate our podcast on iTunes!

Please give us feedback, corrections, and suggestions!
Email feedback to:

Today’s speakers have the following disclosures:

Drs. Lee and Kalangara have nothing to disclose.
Dr. Fineman Speaker: AstraZenca, Boehringer Ingelheim, Shire; Research: Aimmune, DBV, Shire, Regeneron.

We’re pleased to introduce CME credit for this episode of AllergyTalk! Get credit for this episode.

ACAAI presents this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to the procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that may be referenced.